SAFETY, CLINICAL AND IMAGING OUTCOMES OF A NOVEL, INTRA-ARTICULAR, INJECTABLE, WNT INHIBITOR (SM04690) IN THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE: EXPLORATORY ANALYSIS OF RESULTS FROM A 24 WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 STUDY

被引：0
|
作者：
Yazici, Y. [1 ]
McAlindon, T. E. [2 ]
Fleischmann, R. M. [3 ]
Gibofsky, A. [4 ]
Lane, N. E. [5 ]
Kivitz, A. J. [6 ]
Majumdar, S. [7 ]
Strand, V. [8 ]
Swearingen, C. J. [1 ]
DiFrancesco, A. [1 ]
Tambiah, J. [1 ]
Hood, J. [1 ]
Hochberg, M. C. [9 ]
机构：
[1] Samumed LLC, San Diego, CA USA
[2] Tufts Med Ctr, Boston, MA USA
[3] Metroplex Clin Res Ctr, Dallas, TX USA
[4] Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA
[5] Univ Calif Davis, Davis, CA 95616 USA
[6] Altoona Arthrit & Osteoporosis Ctr, Altoona, PA USA
[7] Univ Calif San Francisco, San Francisco, CA 94143 USA
[8] Stanford Univ, Palo Alto, CA 94304 USA
[9] Univ Maryland, Med Ctr, Baltimore, MD 21201 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.1735
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0428
引用
收藏
页码：826 / 826
页数：1
相关论文
共 50 条
  • [21] Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial
    Rossini, Maurizio
    Adami, Silvano
    Fracassi, Elena
    Viapiana, Ombretta
    Orsolini, Giovanni
    Povino, Maria Rosaria
    Idolazzi, Luca
    Gatti, Davide
    RHEUMATOLOGY INTERNATIONAL, 2015, 35 (02) : 255 - 263
  • [22] RESULTS FROM A 52-WEEK, PHASE 2A STUDY OF AN INTRA- ARTICULAR, WNT PATHWAY INHIBITOR, SM04690, FOR KNEE OSTEOARTHRITIS
    Yazici, Y.
    Mcalindon, T.
    Gibofsky, A.
    Lane, N.
    Clauw, D.
    Swearingen, C.
    Difrancesco, A.
    Tambiah, J.
    Hochberg, M.
    OSTEOPOROSIS INTERNATIONAL, 2018, 29 : S51 - S52
  • [23] Assessment of Health-Related Quality of Life in a 52-Week, Phase 2, Randomized, Controlled Trial of a Novel, Intra-Articular, Wnt Pathway Inhibitor (SM04690) for Treatment of Knee Osteoarthritis
    Strand, Vibeke
    Ghandehari, Heli
    Swearingen, Christopher
    Tambiah, Jeyanesh
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [24] Efficacy and safety of intra-articular injection of tropomyosin receptor kinase A inhibitor in painful knee osteoarthritis: a randomized, double-blind and placebo-controlled study
    Krupka, E.
    Jiang, G. -L.
    Jan, C.
    OSTEOARTHRITIS AND CARTILAGE, 2019, 27 (11) : 1599 - 1607
  • [25] EFFECTS OF INTRA-ARTICULAR CLODRONATE IN THE TREATMENT OF KNEE OSTEOARTHRITIS: RESULTS OF A DOUBLE-BLIND, RANDOMISED PLACEBO-CONTROLLED TRIAL
    Orsolini, G.
    Idolazzi, L.
    Rossini, M.
    Viapiana, O.
    Fracassi, E.
    Povino, M.
    Risoli, M.
    Gatti, D.
    Adami, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 745 - 745
  • [26] PROSPECTIVE COMPARISON OF INTRA-ARTICULAR SHAM VS. PLACEBO INJECTIONS: DATA FROM A RANDOMIZED, CONTROLLED PHASE 2B TRIAL OF SM04690, A WNT PATHWAY INHIBITOR FOR KNEE OSTEOARTHRITIS
    Yazici, Y.
    Tambiah, J.
    Swearingen, C.
    Kennedy, S.
    Strand, V.
    Cole, B.
    Hochberg, M.
    Bannuru, R.
    McAlindon, T.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S519 - S520
  • [27] Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study
    Kuah, D.
    Sivell, S.
    Longworth, T.
    James, K.
    Guermazi, A.
    Cicuttini, F.
    Wang, Y.
    Craig, S.
    Comin, G.
    Robinson, D.
    Wilson, J.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2018, 16
  • [28] Safety, tolerability and efficacy of intra-articular Progenza in knee osteoarthritis: a randomized double-blind placebo-controlled single ascending dose study
    D. Kuah
    S. Sivell
    T. Longworth
    K. James
    A. Guermazi
    F. Cicuttini
    Y. Wang
    S. Craig
    G. Comin
    D. Robinson
    J. Wilson
    Journal of Translational Medicine, 16
  • [29] INTEGRATED SAFETY SUMMARY OF THE NOVEL, INTRA-ARTICULAR AGENT LORECIVIVINT (SM04690), A CLK/DYRK1A INHIBITOR THAT MODULATES THE WNT PATHWAY, IN SUBJECTS WITH KNEE OSTEOARTHRITIS
    Simsek, I.
    Swearingen, C.
    Kennedy, S.
    Tambiah, J.
    Damatarca, C.
    Yazici, Y.
    Lane, N.
    Hochberg, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 117 - 117
  • [30] INTEGRATED SAFETY SUMMARY OF THE NOVEL, INTRA-ARTICULAR AGENT LORECIVIVINT (SM04690), A CLK/DYRK1A INHIBITOR THAT MODULATES THE WNT PATHWAY, IN SUBJECTS WITH KNEE OSTEOARTHRITIS
    Kennedy, Sarah
    Simsek, Ismail
    Swearingen, Christopher J.
    Tambiah, Jeyanesh
    Damatarca, Cristina
    Yazici, Yusuf
    Lane, Nancy E.
    Hochberg, Marc C.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 121 - 121
12345